Porcine Epidemic Diarrhea Vaccines Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4145083
- 106 Pages
- December 2020
- Healthcare
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Porcine Epidemic Diarrhea Vaccines market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Porcine Epidemic Diarrhea Vaccines market segmented into
Live Vaccines
Killed Vaccines
Based on the end-use, the global Porcine Epidemic Diarrhea Vaccines market classified into
Piglets
Adults Pigs
Based on geography, the global Porcine Epidemic Diarrhea Vaccines market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
CAVAC
Green Cross Veterinary Products
Harrisvaccines, Inc.
Komipharm
Nisseiken Co., Ltd.
Qilu Animal Health
Zoetis
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PORCINE EPIDEMIC DIARRHEA VACCINES INDUSTRY
2.1 Summary about Porcine Epidemic Diarrhea Vaccines Industry
2.2 Porcine Epidemic Diarrhea Vaccines Market Trends
2.2.1 Porcine Epidemic Diarrhea Vaccines Production & Consumption Trends
2.2.2 Porcine Epidemic Diarrhea Vaccines Demand Structure Trends
2.3 Porcine Epidemic Diarrhea Vaccines Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Live Vaccines
4.2.2 Killed Vaccines
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Piglets
4.3.2 Adults Pigs
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Live Vaccines
5.2.2 Killed Vaccines
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Piglets
5.3.2 Adults Pigs
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Live Vaccines
6.2.2 Killed Vaccines
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Piglets
6.3.2 Adults Pigs
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Live Vaccines
7.2.2 Killed Vaccines
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Piglets
7.3.2 Adults Pigs
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Live Vaccines
8.2.2 Killed Vaccines
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Piglets
8.3.2 Adults Pigs
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Live Vaccines
9.2.2 Killed Vaccines
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Piglets
9.3.2 Adults Pigs
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 CAVAC
10.1.2 Green Cross Veterinary Products
10.1.3 Harrisvaccines, Inc.
10.1.4 Komipharm
10.1.5 Nisseiken Co., Ltd.
10.1.6 Qilu Animal Health
10.1.7 Zoetis
10.2 Porcine Epidemic Diarrhea Vaccines Sales Date of Major Players (2017-2020e)
10.2.1 CAVAC
10.2.2 Green Cross Veterinary Products
10.2.3 Harrisvaccines, Inc.
10.2.4 Komipharm
10.2.5 Nisseiken Co., Ltd.
10.2.6 Qilu Animal Health
10.2.7 Zoetis
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
Table Porcine Epidemic Diarrhea Vaccines Product Type Overview
Table Porcine Epidemic Diarrhea Vaccines Product Type Market Share List
Table Porcine Epidemic Diarrhea Vaccines Product Type of Major Players
Table Brief Introduction of CAVAC
Table Brief Introduction of Green Cross Veterinary Products
Table Brief Introduction of Harrisvaccines, Inc.
Table Brief Introduction of Komipharm
Table Brief Introduction of Nisseiken Co., Ltd.
Table Brief Introduction of Qilu Animal Health
Table Brief Introduction of Zoetis
Table Products & Services of CAVAC
Table Products & Services of Green Cross Veterinary Products
Table Products & Services of Harrisvaccines, Inc.
Table Products & Services of Komipharm
Table Products & Services of Nisseiken Co., Ltd.
Table Products & Services of Qilu Animal Health
Table Products & Services of Zoetis
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Porcine Epidemic Diarrhea Vaccines Market Forecast (Million USD) by Region 2021f-2026f
Table Global Porcine Epidemic Diarrhea Vaccines Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Porcine Epidemic Diarrhea Vaccines Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Porcine Epidemic Diarrhea Vaccines Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
